Importance Tranexamic acid (TXA) is an efficient antifibrinolytic agent; however, concerns
remain about the potential adverse effects, particularly vascular occlusive events, that may …

Introduction: We performed a systematic review and meta-analysis of the current literature to
assess the efficacy and safety of tranexamic acid (TXA) in the management of postoperative …

Objectives To assess the efficacy and safety of single‐dose tranexamic acid on the blood
transfusion rate and outcomes of patients with complex kidney stones undergoing …

Objectives To conduct a systematic review of tranexamic acid (TXA) and the risk of renal
failure from urinary clots in adult patients with hematuria. Methods A systematic review of …

METHODS A comprehensive search was conducted from the following databases: PubMed,
Embase, Cochrane Library, and Web of Science. Two reviewers performed title and abstract …

Purpose: We performed a systematic review and meta-analysis of the literature to evaluate
the efficacy of the routine use of tranexamic acid (TXA) during percutaneous …

Background Perioperative bleeding is associated with increased morbidity and mortality in
patients undergoing elective abdominal surgery. The antifibrinolytic agent tranexamic acid …

Background Percutaneous nephrolithotomy (PCNL) is the gold standard for the treatment of
large kidney stones but comes with an increased risk of bleeding compared to other …

Objective A systematic review and meta-analysis was conducted to explore the efficacy of
tranexamic acid (TXA) in reducing transfusion events in patients undergoing percutaneous …

Abstract Purpose of Review The purpose of current systematic review and meta-analysis is
to determine the efficacy and safety of the administration of tranexamic acid in patients …